Literature DB >> 10447798

Effects of central and peripheral injection of leptin on food intake and on brain Fos expression in the Otsuka Long-Evans Tokushima Fatty rat with hyperleptinaemia.

M Niimi1, M Sato, R Yokote, S Tada, J Takahara.   

Abstract

Hyperleptinaemia is observed in obese animals and humans, suggesting that leptin resistance rather than leptin deficiency is a characteristic feature of obesity. This study was designed to determine whether peripherally or centrally administered leptin is effective on the short-term food intake and expression of Fos protein in the hypothalamus in the Otsuka Long-Evans Tokushima Fatty (OLETF) or Long-Evans Tokushima Otsuka (LETO) rat, as a control. The OLETF rat exhibits a polygenic syndrome of hyperphagia, obesity, hyperinsulinaemia, and hyperglycaemia. Male OLETF rats of 5, 8, and 14 weeks of age became heavier than LETO rats. Serum leptin concentrations were not significantly different between LETO and OLETF rats at the age of 5 weeks, but in 8- and 14-week-old OLETF rats were increased to 3.4 and 2.9 times those of LETO rats, respectively. The 8-week-old OLETF and LETO rats were given intraperitoneal (i.p.) injections with recombinant mouse leptin to measure the kinetics. There was a dramatic increase in plasma leptin concentration at 1 h, a decline by 3 h, and the concentrations 6 h after injection were similar to the basal levels. There were no significant difference between OLETF and LETO rats. In LETO rats at 5, 8 and 14 weeks of age, i.p. injection of leptin significantly decreased food intake. Whereas 5-week-old OLETF rats responded to leptin with a decrease in food intake, 8- and 14-week-old OLETF rats became resistant to peripherally administered leptin. In contrast, intracerebroventricular (i.c.v.) injections of leptin were very effective in inhibiting food intake in both OLETF and LETO rats at 14 weeks of age. Intraperitoneal injection of leptin in the LETO rats at each age increased the number of Fos-positive nuclei detected in the ventromedial hypothalamic (VMH), the dorsomedial hypothalamic (DMH) and arcuate nuclei, whereas there was no significant increase in the number of cells expressing c-fos protein in the hypothalamus of the 8- and 14 week-old OLETF rats with hyperleptinaemia. On the other hand, increased expression of c-fos protein in the VMH, DMH and arcuate nuclei following i.c.v. injection of leptin was observed in both OLETF and LETO rats at 5, 8 and 14 weeks of age. These data demonstrated that obese OLETF rats are peripherally leptin resistant, while they retain sensitivity to centrally administered leptin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447798     DOI: 10.1046/j.1365-2826.1999.00368.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  25 in total

1.  Feeding and reward: ontogenetic changes in an animal model of obesity.

Authors:  Asaf Marco; Mariana Schroeder; Aron Weller
Journal:  Neuropharmacology       Date:  2012-03-01       Impact factor: 5.250

2.  Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats.

Authors:  Michio Niimi
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

3.  Cocaine- and amphetamine-regulated transcript (CART) peptide immunoreactivity in feeding- and reward-related brain areas of young OLETF rats.

Authors:  Simon Armbruszt; Hajnalka Abraham; Maria Figler; Tamas Kozicz; Andras Hajnal
Journal:  J Chem Neuroanat       Date:  2013-03-29       Impact factor: 3.052

4.  Systemic leptin dose-dependently increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei.

Authors:  James W Maniscalco; Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

5.  Neuropeptide W as a stress mediator in the hypothalamus.

Authors:  Michio Niimi; Koji Murao
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

6.  A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

Authors:  V Cano; B Merino; L Ezquerra; B Somoza; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

7.  Serum leptin concentration is linked to chromosomes 2 and 6 in the OLETF rat, an animal model of type 2 diabetes with mild obesity.

Authors:  Tomoe Ogino; Daniel H Moralejo; Hiroyuki Kose; Takahisa Yamada; Kozo Matsumoto
Journal:  Mamm Genome       Date:  2003-12       Impact factor: 2.957

8.  A leptin-mediated central mechanism in analgesia-enhanced opioid reward in rats.

Authors:  Grewo Lim; Hyangin Kim; Michael F McCabe; Chiu-Wen Chou; Shuxing Wang; Lucy L Chen; John J A Marota; Anne Blood; Hans C Breiter; Jianren Mao
Journal:  J Neurosci       Date:  2014-07-16       Impact factor: 6.167

Review 9.  From feeding one to feeding many: hormone-induced changes in bodyweight homeostasis during pregnancy.

Authors:  Rachael A Augustine; Sharon R Ladyman; David R Grattan
Journal:  J Physiol       Date:  2007-11-22       Impact factor: 5.182

10.  Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake.

Authors:  James V Gardiner; Attia Bataveljic; Neekhil A Patel; Gavin A Bewick; Debabrata Roy; Daniel Campbell; Hannah C Greenwood; Kevin G Murphy; Saira Hameed; Preeti H Jethwa; Francis J P Ebling; Steven P Vickers; Sharon Cheetham; Mohammad A Ghatei; Stephen R Bloom; Waljit S Dhillo
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.